All-in-one solution for widefield and confocal imaging

CrestOptics, a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, has announced the launch of its new spinning disc confocal microscope system, Cicero. Focusing on the essential elements of epi-fluorescence and confocal microscopy, Cicero has been developed to make high-end imaging accessible to the wider scientific community by providing a compact and cost-effective system for powerful imaging solutions.

The new system is an all-in-one solution for widefield and confocal imaging. Building on the recent success of the company’s DeepSIM module the new product has been developed to expand the company’s portfolio and enable accessible fluorescence imaging within one compact, budget-friendly, yet high-performing solution. The spinning disc confocal instrument can be easily integrated into existing workflows, with maximum configuration flexibility to support a seamless and user friendly transition, enabling a broad range of imaging applications across basic and applied research.

The compact system facilitates streamlined transition between widefield and confocal imaging, enabling users to simply switch between modes as their imaging requirements evolve. Widefield mode supports informative data collection from samples, such as cell monolayers and tissue sections, whereas the confocal mode allows higher-quality analysis of larger 3D structures, including organoids or whole organisms. Additionally, Cicero’s speed and light efficiency provides the capability for prolonged live imaging and the capture of fast cellular events, such as chromosome segregations and organelle trafficking.

Alessandra Scarpellini, chief commercial officer, CrestOptics, said “We realised that there was a need for an instrument that was equally powerful and easy to integrate into different platforms. Our team have worked hard to ensure that Cicero retains the level of technological excellence and performance that we provide in our existing portfolio, whilst ensuring that the instrument was compact and cost-effective.”

Recent Issues